Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Vemurafenib and BRAF inhibition: a new class of treatment for metastatic melanoma.

Luke JJ, Hodi FS. Vemurafenib and BRAF inhibition: a new class of treatment for metastatic melanoma. Clin Cancer Res. 2012 Jan 01; 18(1):9-14.

View in: PubMed

collapse authors with profiles